PLUR

Pluristem Therapeutics Inc. develops and commercializes cell-based products utilizing its proprietary 3D cell expansion technology. The company operates primarily in the fields of regenerative medicine and food technology, focusing on scalable solutions for applications such as cell therapy and sustainable food production. Pluristem serves various industries, including healthcare and food-tech, and aims to establish partnerships to expand its technology's reach across additional sectors. The company is headquartered in Haifa, Israel, and is publicly traded.